Monkeypox stocks
We just got out of a pandemic and it is not the time to go into another one. The economy is weaker and inflation is higher so we can't afford to lock down again.
World Health Organisation (WHO) has declared global emergency for Monkeypox on Saturday after 16,000 cases has been detected in more than 75 countries.
Although it sounds scary, I don't think Monkeypox can reach the scale of Covid. But don't take my word for it because I am not a medical expert and I am just interpreting news as they come along.
My understanding is that Monkeypox can only be transmitted through close and prolonged contact with an infected person, and largely it has been confined to men. Death rate doesn't seem to be high too. Hence, I don't think lockdowns are necessary unless the virus evolves to be more deadly.
There are currently two vaccines approved by the Federal Drug Administration (FDA). JYNNEOS by a Danish drug maker, Bavarian Nordic and ACAM2000 by a French pharma, Sanofi.
Please note that this is NOT a prescription for the disease and I am looking at the situation as a financially motivated trader.
Bavarian Nordic is listed in Denmark but has an OTC counter trading in the US under the ticker BVNRY. Share price has risen 16% year-to-date.
Sanofi is listed in France under the ticker SAN and its share price has gone up 10% this year.
Lastly, oral antivirals (pills) are available too. Centers for Disease Control and Prevention (CDC) has listed four drugs under its interim guidance.
Tecovirimat is by SIGA Technologies. $SIGA Technologies (SIGA.US)$ SIGA share price has gone up 60% this year.
Vaccinia Immune Globulin Intravenous is made by Cangene, a subsidiary of a privately owned Canadian pharma, Apotex.
Cidofovir is made by Gilead but has since been discontinued.
Brincidofovir is made by Chimerix (CMRX). The share price has performed badly, down 73% this year. Probably due to the risk-off appetite from investors as Chimerix is still losing money and revenue has been erratic.
Note that these stocks are usually not good long-term investments and are meant for event-driven short term trades at best.
Just like Covid vaccine plays, Pfizer, BioNTech and Moderna went up by 22%, 871% and 2,090% between 1 Jan 2020 and 6 Aug 2021 respectively.
Momentum strategies would be best for such plays.
World Health Organisation (WHO) has declared global emergency for Monkeypox on Saturday after 16,000 cases has been detected in more than 75 countries.
Although it sounds scary, I don't think Monkeypox can reach the scale of Covid. But don't take my word for it because I am not a medical expert and I am just interpreting news as they come along.
My understanding is that Monkeypox can only be transmitted through close and prolonged contact with an infected person, and largely it has been confined to men. Death rate doesn't seem to be high too. Hence, I don't think lockdowns are necessary unless the virus evolves to be more deadly.
There are currently two vaccines approved by the Federal Drug Administration (FDA). JYNNEOS by a Danish drug maker, Bavarian Nordic and ACAM2000 by a French pharma, Sanofi.
Please note that this is NOT a prescription for the disease and I am looking at the situation as a financially motivated trader.
Bavarian Nordic is listed in Denmark but has an OTC counter trading in the US under the ticker BVNRY. Share price has risen 16% year-to-date.
Sanofi is listed in France under the ticker SAN and its share price has gone up 10% this year.
Lastly, oral antivirals (pills) are available too. Centers for Disease Control and Prevention (CDC) has listed four drugs under its interim guidance.
Tecovirimat is by SIGA Technologies. $SIGA Technologies (SIGA.US)$ SIGA share price has gone up 60% this year.
Vaccinia Immune Globulin Intravenous is made by Cangene, a subsidiary of a privately owned Canadian pharma, Apotex.
Cidofovir is made by Gilead but has since been discontinued.
Brincidofovir is made by Chimerix (CMRX). The share price has performed badly, down 73% this year. Probably due to the risk-off appetite from investors as Chimerix is still losing money and revenue has been erratic.
Note that these stocks are usually not good long-term investments and are meant for event-driven short term trades at best.
Just like Covid vaccine plays, Pfizer, BioNTech and Moderna went up by 22%, 871% and 2,090% between 1 Jan 2020 and 6 Aug 2021 respectively.
Momentum strategies would be best for such plays.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
